| Patents for C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes (141,535) |
|---|
| 05/22/2002 | EP1206552A2 Tryptase-like polypeptide ztryp1 |
| 05/22/2002 | EP1206551A2 Enzymatic synthesis of deoxyribonucleosides |
| 05/22/2002 | EP1206529A2 UDP-N-ACETYLGLUCOSAMINE: GALACTOSE-BETA 1,3-N-ACETYLGALACTOSAMINE-ALPHA-R/(GlcNAc to GalNAc) BETA 1,6-N-ACETYLGLUCOSAMINYLTRANSFERASE, C2GnT3 |
| 05/22/2002 | EP1206528A2 Chimeric dna/rna ribozymes containing propanediol |
| 05/22/2002 | EP1206527A1 Treatment of inflammatory or malignant disease using dnazymes |
| 05/22/2002 | EP1206526A2 Subtilisin protease variants having amino acid deletions and substitutions in defined epitope regions |
| 05/22/2002 | EP1206495A1 Chimeric polypeptides, method for production and uses thereof |
| 05/22/2002 | EP1206484A2 Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis |
| 05/22/2002 | EP1206483A2 Automated protein purification in the multiwell format by vacuum filtration |
| 05/22/2002 | EP1206242A1 Use of bacterial extracts of the pseudomonadaceae family as cosmetic agents |
| 05/22/2002 | EP1206233A2 Serine proteases |
| 05/22/2002 | EP1049487B1 Treatment of acute intermittent porphyria (aip) and other porphyric diseases |
| 05/22/2002 | EP0665754B1 Antimicrobial peptides |
| 05/22/2002 | EP0437599B1 Cell lineages expressing a biologically active factor ix |
| 05/22/2002 | CN1350589A Process for the fermentative preparation of L-amino acids with amplification of the TKT gene |
| 05/22/2002 | CN1350586A Process for the fermentative preparation of L-amino acids with amplification of the GND gene |
| 05/22/2002 | CN1350582A Method for generating split, non-transferable genes that are able to express an active protein product |
| 05/22/2002 | CN1350579A 葡萄糖脱氢酶 Glucose dehydrogenase |
| 05/22/2002 | CN1350547A Alleviation of the alelrgenic potential of airborne and contact allergens by thioredoxin |
| 05/22/2002 | CN1350545A Spray drying of thrombin inhibitors |
| 05/22/2002 | CN1350060A Phytase gene and its cloning |
| 05/22/2002 | CN1085254C Process for producing cis-3-hydroxyl-L-proline |
| 05/22/2002 | CN1085253C Process for producing trnas-4-hydroxy-L-proline |
| 05/21/2002 | US6392126 Nucleotide sequence coding enzymatic polypeptide; for use as diagnostic tool in genetic engineering |
| 05/21/2002 | US6392120 Modification of starch biosynthetic enzyme gene expression to produce starches in grain crops |
| 05/21/2002 | US6392119 Genetically engineered plant for use biological pest control and cancer therapy |
| 05/21/2002 | US6392030 Strawberry promoters and genes |
| 05/21/2002 | US6392013 Redirection of cellular immunity by protein tyrosine kinase chimeras |
| 05/21/2002 | US6391858 Gene delivery in various muscle cell types; gene therapy for expression of erythropoietin to treat blood disorders such as anemias, for example |
| 05/21/2002 | US6391853 Human tissue inhibitor of metalloproteinase-4 |
| 05/21/2002 | US6391651 Materials and methods for detection of insulin dependent diabetes |
| 05/21/2002 | US6391640 Methods and compositions for cellular and metabolic engineering |
| 05/21/2002 | US6391613 Motor proteins and methods for their use |
| 05/21/2002 | US6391612 Replicating preferential plasmids; obtain nuclelotide sequences, transform cells, allow replication, recover plasmids |
| 05/21/2002 | US6391611 Nucleotide sequences coding polypeptide for use generation of biodegradable plastics |
| 05/21/2002 | US6391610 Nucleotide sequences coding enzymatic polypeptide for use in the treatment of extracellular matrix defects |
| 05/21/2002 | US6391609 Generation solution containing blood proteins; extract mammalian tissue, separate coagulaton factors, recover purfied blood protein |
| 05/21/2002 | US6391608 Method for cloning and expression of PleI restriction endonuclease and PleI and BstNBII methylases in E. coli |
| 05/21/2002 | US6391607 Human DNase I hyperactive variants |
| 05/21/2002 | US6391606 Peptides; for use in the develoment of human diagnostic and therapeutic agents |
| 05/21/2002 | US6391605 Modified phytases |
| 05/21/2002 | US6391604 Thermostable enzyme having phosphatidylethanolamine N-methyltransferase activity |
| 05/21/2002 | US6391603 Genes of purine biosynthesis from Ashbya gossypii and the use thereof in microbial riboflavin synthesis |
| 05/21/2002 | US6391602 Polypeptide for use in the treatment of cardiovascular disorders |
| 05/21/2002 | US6391601 Transport protein for use in the treatment of cell proliferation defects, cancer, hyperplasias, restenosis, cardiovascular, immune and inflammatory disorders |
| 05/21/2002 | US6391600 PcrA helicase |
| 05/21/2002 | US6391599 Nucleotide sequences coding enzymatic polypeptide for use in the generation of ethanol |
| 05/21/2002 | US6391597 Generating preferential carboxylic acid compound; obtain preferential ester, incubate hydrolase, recover preferential compound |
| 05/21/2002 | US6391595 Transferase and amylase, process for producing the enzymes, use thereof, and gene coding for the same |
| 05/21/2002 | US6391594 Generating nucleotide sequence encoding genetically engineered polyketide synthase; obtain nucleotide sequences, insert into expression vectors, transform cells, recover enzymatic polypeptide |
| 05/21/2002 | US6391574 AFC1 and RCE1: isoprenylated CAAX processing enzymes |
| 05/21/2002 | US6391573 Contacting protein having microtubule stimulated atpase (adenosine triphosphatase) activity with compound at several different concentrations and measuring activity of protein; difference in activity indicates modulator |
| 05/21/2002 | US6391557 Using recombinantly expressed mismatch endonuclease from a plant to determine a mutation in the target sequence of a single-stranded polynucleotide which is hybridized to a non-mutated sequence |
| 05/21/2002 | US6391554 Detecting cancerous conditions by assaying for telomerase activity |
| 05/21/2002 | US6391547 Microbial β-glucuronidase genes, gene products and uses thereof |
| 05/21/2002 | US6391311 Polypeptide comprising amino acid sequence at least about 80% identical to specified sequence, which has biological activity of promoting selective growth and/or survival of human umbilical vein endothelial cells in in vitro assay |
| 05/21/2002 | US6391298 Method of using PON-1 to decrease atheroma formation |
| 05/21/2002 | US6390821 Phosphorylation |
| 05/21/2002 | CA2215310C Substrates for beta-lactamase and uses thereof |
| 05/21/2002 | CA2183241C Yeast strains and modified albumins |
| 05/21/2002 | CA2153254C Cloning of enterokinase and method of use |
| 05/21/2002 | CA2039706C Method for preparing amino acid derivatives and therapeutical applications of same |
| 05/17/2002 | CA2363147A1 Stable lactase compositions |
| 05/16/2002 | WO2002038797A2 Modulators of bruton's tyrosine kinase, their identification and use |
| 05/16/2002 | WO2002038788A2 Process for the fermentative preparation of l-amino acids using coryneform bacteria |
| 05/16/2002 | WO2002038786A1 Ethanol process |
| 05/16/2002 | WO2002038784A1 Enzyme catalysis in the presence of ionic liquids |
| 05/16/2002 | WO2002038780A2 Use of a nucleic acid to provide a plant with resistance to attack by a pathogen |
| 05/16/2002 | WO2002038777A2 Enzymes and encoding genes from methylophilus methylotrophus |
| 05/16/2002 | WO2002038776A1 Regulation of human fatty acid coa ligase |
| 05/16/2002 | WO2002038775A2 METHODS FOR PRODUCING AND PURIFYING RECOMBINANT α-L-IDURONIDASE |
| 05/16/2002 | WO2002038774A2 Bacterial phytases and method for producing same |
| 05/16/2002 | WO2002038773A2 A human phospholipase c and uses thereof |
| 05/16/2002 | WO2002038772A1 Nucleotide sequences which code for the nadc gene |
| 05/16/2002 | WO2002038771A1 Drug-tolerant hiv integrases |
| 05/16/2002 | WO2002038762A1 Method of acquiring gene specific to nerve formation of vertebrate |
| 05/16/2002 | WO2002038754A1 Cellulase preparation containing nonionic surfactant and method of treating fiber |
| 05/16/2002 | WO2002038750A1 Methods for isolating novel antimicrobial agents from hypermutable mammalian cells |
| 05/16/2002 | WO2002038748A2 Mammalian sex selection using genetic modification |
| 05/16/2002 | WO2002038747A2 Human adenylate cyclase |
| 05/16/2002 | WO2002038746A2 Novel thermostable alkaliphilic xylanase |
| 05/16/2002 | WO2002038745A2 Regulation of mitogen-activated protein kinase (mapk) |
| 05/16/2002 | WO2002038744A2 Proteases |
| 05/16/2002 | WO2002038743A2 Deaminase catalyzing the removal of the cyclopropyl moiety from abacavir-mp |
| 05/16/2002 | WO2002038742A2 Dipeptidylpeptidases and methods of use |
| 05/16/2002 | WO2002038740A1 Recombinant zymomonas mobilis with improved xylose utilization |
| 05/16/2002 | WO2002038739A1 Bacterial expression systems |
| 05/16/2002 | WO2002038736A2 Methods for regulating plant gaba production |
| 05/16/2002 | WO2002038732A2 Human testis specific serine/threonine kinase |
| 05/16/2002 | WO2002038727A2 Dna sequences encoding proteins conferring phytophthora infestans resistance on plants |
| 05/16/2002 | WO2002038717A1 Catalase as an oxidative stabilizer in solid particles and granules |
| 05/16/2002 | WO2002038613A2 Modified recombinase |
| 05/16/2002 | WO2002038598A1 Nucleotide sequences which code for the nada gene |
| 05/16/2002 | WO2002038589A2 Haplotypes of the cyp2d6 gene |
| 05/16/2002 | WO2002038588A2 Putrescine-n-methyltransferase promoter |
| 05/16/2002 | WO2002038585A2 Haplotypes of the gss gene |
| 05/16/2002 | WO2002038179A1 Preventives or remedies for endoplasmic reticulum stress-associated diseases |
| 05/16/2002 | WO2002038171A2 METHODS FOR TREATING DISEASES CAUSED BY DEFICIENCIES OF α-L-IDURONIDASE |
| 05/16/2002 | WO2002038162A1 MODIFIED FACTOR VIIa |
| 05/16/2002 | WO2002037955A1 Barley with reduced ssii activity and starch containing products with a reduced amylopectin content |